[Retracted] Immunopathology and Immunogenetics of Allergic Bronchopulmonary Aspergillosis

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left">(i) HLA-DR restriction and HLA-DQ protection</td></tr><tr><td align="left"> (a) HLA-DR2 restriction</td></tr><tr><td align="left">    HLA-DRB1*1501 and *HLA-DRB1*1503</td></tr><tr><td align="left">  (b) HLA-DR5</td></tr><tr><td align="left">    HLA-DRB1*1104</td></tr><tr><td align="left">  (c) HLA-DQ2 protective, decreased in ABPA</td></tr><tr><td align="left">    DQB1*0201</td></tr><tr><td align="left">(ii)<i> IL-4RA</i> polymorphisms</td></tr><tr><td align="left"> (a) <i>IL-4RA</i> ile75val</td></tr><tr><td align="left">(iii) IL-10 polymorphisms</td></tr><tr><td align="left">  (a) Promoter −1082 GG genotype</td></tr><tr><td align="left">(iv) Surfactant protein A2 (<i>SP-A2</i>) polymorphisms</td></tr><tr><td align="left">  (a)<i> SP-A2</i> ala91pro</td></tr><tr><td align="left">(v) Cystic fibrosis transmembrane conductance regulator  (<i>CFTR</i>) mutations</td></tr><tr><td align="left">  (a) Heterozygous <i>CFTR</i> mutations in asthmatic patients  with ABPA</td></tr><tr><td align="left">(vi) Toll-like receptor (<i>TLR</i>) polymorphisms</td></tr><tr><td align="left">  (a)<i> TLR9 </i>T-1237C polymorphism</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Genetic risk factors in the development of allergic bronchopulmonary aspergillosis.

Journal of Allergy

tab1

Table 1

Table 1: [Retracted] Immunopathology and Immunogenetics of Allergic Bronchopulmonary Aspergillosis 